|
인쇄하기
취소
|
Hepatitis B patients with renal failure to benefit from more health insurance
Published: 2008-08-19 06:58:00
Updated: 2008-08-19 06:58:00
Hepatitis B patients with renal insufficiency will have more health insurance allowance for clevudine as Bukwang completed its dose-modifying studies.
The company will make its additional license application to the Korea Food and Drug Administration so that doctors can adjust the dose depending on individual patients.
Clevudine is an oral, once-daily pyrimidine nucleoside analog that has ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.